ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260273.1	Docetaxel	Bladder urothelial carcinoma	0.030062036	Resistant
ENSG00000260273.1	Docetaxel	Breast invasive carcinoma	0.017957637	Resistant